EHA announces a New Era of Partnership with Interplan!
Extract from the EHA press release:
The European Hematology Association (EHA) is delighted to announce to the conference and meeting community the outcome of its Core PCO Invitation To Tender (ITT). EHA looks forward to a new era with its newly appointed partner Interplan for the next three Congress editions in 2023, 2024 and 2025.
Following a rigorous ITT timeframe, which commenced in September, the initial Request for Information (RFI) was released mid-October to seek interest from qualified PCOs. This was followed by the issuance of the formal Invitation To Tender (ITT) to preselected PCO's in early November.
Mr Rik Craenmehr, Head of Congress & Meetings of the European Hematology Association, said
"We are delighted with the outcome of a highly technical process and express our heartiest congratulations to Interplan as new PCO Partner.
We received an excellent response from a selection of PCOs of an extremely high caliber, all of whom were professional and capable to deliver to our needs. We commend the efforts, support and engagement demonstrated by all of them, and we wish to express our heartfelt appreciation to each of them.
After a stringent evaluation process, it came down to the organizational fit and the ability to evaluate and align the PCO's capabilities, focus and approach to match those of EHA at the present. We need a strong convergence and balance between where the EHA Congress model is currently at, and where it aspires to be. Interplan will play a crucial role in how we move forward in a very volatile and constantly transforming global landscape. We aim to learn, grow and advance together, with EHA at the forefront".
Dr Markus Preussner, Managing Director Interplan, said
"At Interplan we are tremendously proud and honored to have been appointed by EHA as the new core PCO. Right from the start, our entire team was on fire for this project. We consider it as an exceptional opportunity to support one of the leading European congresses and we are convinced that EHA and Interplan are a perfect match with the common goal of a successful partnership."
The European Hematology Association (EHA) was officially established in 1992 and is a global platform for excellence in hematology, focusing on blood, blood cells, and blood disorders such as leukemia, lymphoma, hemophilia, anemia, and thrombosis.
EHA is the largest Europe-based organization connecting hematologists worldwide to support career development and research, harmonize hematology education, and advocate for hematologists and hematology. It is a non-governmental and not-for-profit membership organization that is guided by its mission to promote excellence in patient care, research, and education in hematology.
EHA holds an annual congress to facilitate that mission and to connect hematologists worldwide.